Acme United's biggest risks in the FY2024 10-K
- Acme United Corp faces significant customer concentration, international supply chain dependencies, and regulatory compliance requirements across its product lines.
The risks most specific to Acme United
- Industry and Operational Risks
The Company’s Westcott business is subject to risks associated with seasonality which could adversely affect its cash flow, financial condition, or results of operations
The Westcott business experiences seasonal sales volume during the back-to-school period from May through August.
- Industry and Operational Risks
Failure to manage growth and continue to expand our operations successfully could adversely affect our financial results
The company relies on strategic acquisitions, such as Hawktree in 2023 and Elite First Aid in 2024, to drive growth.
- Industry and Operational Risks
Loss of a major customer could result in a decrease in the Company’s future sales and earnings
Two major customers accounted for 14% and 13% of consolidated net sales in 2024, creating customer concentration risk.
- Industry and Operational Risks
Although the Company has recently reduced its indebtedness, we continue to borrow under our bank line of credit, which could adversely affect our financial condition and ability to operate our business
The company maintains $17,640,550 outstanding on its revolving credit facility and fixed-rate mortgages on facilities in Rocky Mount, North Carolina and Vancouver, Washington.
- Industry and Operational Risks
Changes in interest rates could adversely affect us
The HSBC Bank revolving credit loan agreement bears interest at SOFR plus 1.70%.
- Industry and Operational Risks
A material weakness in our internal control over financial reporting which could, if not remediated, result in material misstatements in our financial statements
The company identified a material weakness in internal control over financial reporting related to information technology general controls for 2024.
- Legal and Regulatory Risks
Certain or our products and facilities are subject to regulation by the FDA and by analogous foreign regulators
Certain products and facilities are subject to regulation by the FDA and HealthCanada.
- Risks Related to Our Overseas Operations
Reliance on foreign suppliers could adversely affect the Company’s business
The company relies on foreign suppliers located primarily in China, Asia, Europe, and the United States.
- Risks Related to Our Common Stock
Our shares of common stock are thinly traded and our stock price may be volatile
Common stock is thinly traded with approximately 3,289,572 shares held by non-affiliates as of December 31, 2024.
All 35 risk factors
Headings as the filing states them, in filing order.
Industry and Operational Risks
- 01industry demand fluctuations
- 02Changes in United States and foreign laws and policies governing international trade, export controls, manufacturing, and investment in the jurisdictions where we currently source or sell products, and any negative consequences resulting from such changes, could materially affect our business
- 03We expect to continue to experience inflationary pressure on our cost structure, and price increases may not be sufficient to offset cost increases or may result in sales volume declines
- 04The ability to deliver products to our customers in a timely manner and to satisfy our customers’ fulfillment standards are subject to many factors, some of which are beyond our control
- 05If we do not successfully optimize and manage our fulfillment processes, our business, financial condition and operating results could be harmed
- 06problem fulfilling orders in a timely manner, our customers may experience delays in receiving their purchases, which could harm our reputation and our relationship with our customers
- 07Matters relating to the employment market and prevailing wage standards may adversely affect our business
- 08The Company’s Westcott business is subject to risks associated with seasonality which could adversely affect its cash flow, financial condition, or results of operations
- 09Failure to manage growth and continue to expand our operations successfully could adversely affect our financial results
- 10We may be unable to accurately forecast net sales and appropriately plan our expenses in the future
- 11Unfavorable shifts in industry-wide demand for the Company’s products could result in inventory valuation risk
- 12Loss of a major customer could result in a decrease in the Company’s future sales and earnings
- 13Because our products are primarily sold by third parties, our financial results depend in part on the financial health of these parties and any loss of a third-party distributor could adversely affect the Company’s revenues
- 14The loss of key management could adversely affect the Company’s ability to run its business
- 15Execution or the lack thereof, of our e-commerce business may reduce our operating results
- 16The Company is subject to intense competition in all of the markets in which it competes
- 17Compromises of our information systems or unauthorized access to confidential information or our customers' or associates' personal information may materially harm our business or damage our reputation
- 18Although the Company has recently reduced its indebtedness, we continue to borrow under our bank line of credit, which could adversely affect our financial condition and ability to operate our business
- 19These restrictions could adversely affect our financial condition and limit our ability to successfully implement our growth strategy
- 20The Company may need to raise additional capital to fund its operations
- 21Changes in interest rates could adversely affect us
- 22The military conflicts in Ukraine and the Middle East have resulted in geopolitical instability. Our business, financial position, results of operations and cash flows could be adversely affected by the negative impacts on the global economy resulting from these conflicts
- 23A material weakness in our internal control over financial reporting which could, if not remediated, result in material misstatements in our financial statements
Legal and Regulatory Risks
- 24Failure to protect the Company’s proprietary rights or the costs of protecting these rights could adversely affect its business
- 25If the Company is found to have infringed the intellectual property rights of others or cannot obtain necessary intellectual property rights from others, its competitiveness could be negatively impaired
- 26Product liability claims or regulatory actions could adversely affect the Company's financial results and reputation
- 27The Company’s businesses and operations are subject to regulation in the U.S. and abroad
- 28abroad that may require the Company to incur additional personnel-related, environmental or other costs on an ongoing basis, significantly restrict the Company’s ability to sell certain products, or incur fines or penalties for noncompliance, any of which could adversely affect the Company’s results of operations
- 29Certain or our products and facilities are subject to regulation by the FDA and by analogous foreign regulators
- 30The Company is subject to environmental regulation and environmental risks
Risks Related to Our Overseas Operations
- 31The effects of any future pandemics in foreign countries
- 32Reliance on foreign suppliers could adversely affect the Company’s business
- 33Continuing uncertainty in the global economy could negatively impact our business
Risks Related to Our Common Stock
- 34We cannot provide assurance that we will continue to pay dividends or purchase shares of our common stock under our stock repurchase programs
- 35Our shares of common stock are thinly traded and our stock price may be volatile
Other Acme United 10-Ks
- FY2025 10-K risk factors36 risks3 new2 dropped8 reworded
Acme United Corp added operational risks regarding artificial intelligence and new 2025 tariffs on Canada, Mexico, and the EU.
Filed Mar 11, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.